[Malignancies in adult patients with common variable immunodeficiency]. 2015

Eunice López-Rocha, and Karen Rodríguez-Mireles, and Nora Hilda Segura-Méndez, and Marco Antonio Yamazaki-Nakashimada
Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Distrito Federal, México. aeri_05@hotmail.com.

BACKGROUND Common variable immunodeficiency (CVID) implies an increased risk of cancer, with an estimated incidence of 11-13%, particularly during the 5th and 6th decade of life. B cell-Hodgkin lymphomas are the more frequent cancer, followed by non-Hodgkin lymphoma and epithelial tumors (gastric, breast, bladder and cervix). OBJECTIVE To describe the types of cancers in a cohort of adult patients with CVID. METHODS An observational, cross-sectional and descriptive study was made in which we reviewed the charts of patients with CVID attending the Primary Immunodeficiencies Clinic at Specialties Hospital Dr. Bernardo Sepulveda, Centro Medico Nacional Siglo XXI, Mexico City. RESULTS There were included 23 patients with CVID diagnosis, 13 women (56%) and 10 men (44%), with an average age of 36.7 years. Four patients developed malignancies (2 men and 2 women), with a prevalence of 17.3%. The types of cancers in this group of patients were: B cell-Hodgkin lymphoma (1/23), neuroendocrine carcinoma of the pancreas (1/23), myeloid chronic leukemia (1/23) and thyroid papillary carcinoma (1/23). In two of the subjects the diagnosis of cancer was established previous to CVID diagnosis. The average age of diagnosis of cancer was 27 years (19-34 years). CONCLUSIONS In our patients we found different types of malignancies compared to previously described. We consider necessary a screening protocol for an early diagnosis of cancer in these patients. The frequency of cancer in our population was the same as reported in the literature.

UI MeSH Term Description Entries

Related Publications

Eunice López-Rocha, and Karen Rodríguez-Mireles, and Nora Hilda Segura-Méndez, and Marco Antonio Yamazaki-Nakashimada
August 2012, Blood,
Eunice López-Rocha, and Karen Rodríguez-Mireles, and Nora Hilda Segura-Méndez, and Marco Antonio Yamazaki-Nakashimada
January 2018, Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993),
Eunice López-Rocha, and Karen Rodríguez-Mireles, and Nora Hilda Segura-Méndez, and Marco Antonio Yamazaki-Nakashimada
March 2016, The American journal of the medical sciences,
Eunice López-Rocha, and Karen Rodríguez-Mireles, and Nora Hilda Segura-Méndez, and Marco Antonio Yamazaki-Nakashimada
February 2018, International journal of molecular sciences,
Eunice López-Rocha, and Karen Rodríguez-Mireles, and Nora Hilda Segura-Méndez, and Marco Antonio Yamazaki-Nakashimada
January 2012, Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993),
Eunice López-Rocha, and Karen Rodríguez-Mireles, and Nora Hilda Segura-Méndez, and Marco Antonio Yamazaki-Nakashimada
January 2015, Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993),
Eunice López-Rocha, and Karen Rodríguez-Mireles, and Nora Hilda Segura-Méndez, and Marco Antonio Yamazaki-Nakashimada
January 2000, The Indian journal of chest diseases & allied sciences,
Eunice López-Rocha, and Karen Rodríguez-Mireles, and Nora Hilda Segura-Méndez, and Marco Antonio Yamazaki-Nakashimada
June 1998, Diabetes care,
Eunice López-Rocha, and Karen Rodríguez-Mireles, and Nora Hilda Segura-Méndez, and Marco Antonio Yamazaki-Nakashimada
June 2019, Clinical immunology (Orlando, Fla.),
Eunice López-Rocha, and Karen Rodríguez-Mireles, and Nora Hilda Segura-Méndez, and Marco Antonio Yamazaki-Nakashimada
October 2014, Singapore medical journal,
Copied contents to your clipboard!